Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 12

July 31, 2024 16:05 ET AUSTIN, Texas, July 31, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months ended June 30,…

Read More

Aspira Women’s Health Appoints Mr. John Ragard to its Board of Directors

SUMMARY: Mr. Ragard further strengthens the Board bringing more than 46 years of significant public equity investment and Wall Street experience DOWNLOAD THIS POST AUSTIN, Texas, July 29, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today…

Read More